A Mechanism of Resistance to Antibody-Targeted Immune Attack

Targeted monoclonal antibody therapy is a promising therapeutic strategy for cancer and antibody-dependent cell-mediated cytotoxicity (ADCC) represents a crucial mechanism underlying these approaches. The majority of patients have limited responses to monoclonal antibody therapy due to the developme...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Immunol Res
Asıl Yazarlar: Aldeghaither, Dalal S., Zahavi, David J., Murray, Joseph C., Fertig, Elana J., Graham, Garrett T., Zhang, Yong-Wei, O’Connell, Allison, Ma, Junfeng, Jablonski, Sandra A., Weiner, Louis M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6359950/
https://ncbi.nlm.nih.gov/pubmed/30563830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0266
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller